We currently supply more than 70 countries with critical vaccines. This growth means we’re continually investing in production, research and development. Since 2006, Ceva has invested over $65 million in our Lenexa campus. Major projects completed include:
- $18 million - New vaccine manufacturing facility opened Nov. 2011
- $ 7 million - New research and development facility opened June 2013
- $10 million - Expansion of vaccine manufacturing facility opened May 2015
We expect to invest an additional $30 million in the campus between now and 2017.